Clinical Trial

Lifestyle Intervention for Type 2 Diabetes in Primary Care (CREDOenAP)

Study acronym: CREDOenAP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this clinical trial is to determine whether an intensive lifestyle intervention can achieve remission of type 2 diabetes mellitus (T2DM) in adult patients treated in primary care. The main questions the study seeks to answer are: * What proportion of participants achieve diabetes remission after 6 months of intervention? * How many participants maintain remission 12 months after completing the program (18 months total)? Participants will: * Follow a personalized dietary plan with carbohydrate restriction. * Engage in moderate, accessible physical activity. * Implement strategies to improve circadian rhythm regularity. * Receive psychological counseling and support.
Trial Details
NCT Number NCT07207980
Lead Sponsor Parc Sanitari Pere Virgili
Conditions Type 2 Diabetes Mellitus (T2DM)
Enrollment 120 participants
Start Date 2026-01-11
Primary Completion 2027-06-30 (estimated)
Study Completion 2028-01-11 (estimated)
Updated on ClinicalTrials.gov 2025-10-06